Proto-oncogene expression during two-stage carcinogenesis in mouse skin

Area of Science:

• Oncology
• Molecular Biology
• Dermatology

Background:

• Proto-oncogenes play critical roles in cellular growth and differentiation.
• Alterations in proto-oncogene expression are frequently observed in various cancers.
• Understanding proto-oncogene involvement in skin carcinogenesis is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the expression levels of specific proto-oncogenes (rasHa, rasKi, fos, myc, abl, raf) during chemical carcinogenesis in mouse skin.
• To determine if elevated proto-oncogene expression is a prerequisite for tumor initiation and promotion.
• To explore the potential role of the abl gene in epidermal proliferation and differentiation.

Main Methods:

• Quantitative analysis of proto-oncogene expression in chemically induced mouse skin tumors, epidermis, and papillomas.
• Treatment of primary mouse epidermal cells with 12-O-tetradecanoylphorbol-13-acetate (TPA) in vitro.
• Analysis of proto-oncogene expression in cell lines derived from chemically treated epidermal cells.

Main Results:

• No significant increase in the expression of rasHa, rasKi, fos, myc, or raf was observed in tumors or after TPA treatment.
• A consistent reduction in abl gene expression was detected in both papillomas and carcinomas.
• Repeated TPA application and in vitro treatment of epidermal cells with TPA did not induce significant alterations in the expression of the studied proto-oncogenes.

Conclusions:

• Increased expression of the investigated proto-oncogenes is not essential for mouse skin tumor induction.
• The reduced expression of abl in tumors and upon TPA treatment suggests a potential role in epidermal proliferation or differentiation processes.